Verve Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jul '25 Jul 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Market Capitalization	51	44	34	37	35	26	Upgrade
Market Cap Growth	58.65%	31.33%	-8.37%	4.96%	37.28%	-16.24%	Upgrade
Last Close Price	15.80	13.79	10.50	11.46	10.92	7.95	Upgrade
PE Ratio	9.13	8.62	6.83	7.81	11.20	9.73	Upgrade
PS Ratio	2.81	2.62	2.15	2.50	3.01	2.48	Upgrade
PB Ratio	1.12	1.04	0.90	1.14	1.19	0.94	Upgrade
P/FCF Ratio	-	89.40	5.22	8.50	10.34	6.41	Upgrade
P/OCF Ratio	-	17.24	5.12	8.37	10.09	6.26	Upgrade
Debt / Equity Ratio	1.39	1.71	2.27	0.87	0.95	1.04	Upgrade
Debt / FCF Ratio	-	147.65	13.20	6.53	8.30	7.08	Upgrade
Return on Equity (ROE)	13.02%	12.82%	14.14%	15.22%	11.02%	10.17%	Upgrade
Return on Assets (ROA)	1.17%	1.13%	1.17%	1.21%	0.90%	0.96%	Upgrade
Earnings Yield	10.95%	11.60%	14.64%	12.80%	8.93%	10.28%	Upgrade
FCF Yield	-	1.12%	19.15%	11.76%	9.68%	15.60%	Upgrade
Payout Ratio	-	-	0.05%	-	0.08%	-	Upgrade
Buyback Yield / Dilution	-0.00%	-	-	0.01%	-	0.01%	Upgrade

Updated Jan 17, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.